No Prescription |
 |
 | ||
|
TRAZONIL Desyrel |
|
| ||
No Prescription » Prescription Drugs 16 » TRAZONIL Desyrel Trazodone is used to treat depression. Trazodone is in a class of medications called serotonin modulators. It works by increasing the amount of serotonin a natural substance in the brain that helps maintain mental balance.Trazodone comes as a tablet to take by mouth. It is usually taken with a meal or light snack two or more times a day. To help you remember to take trazodone take it around the same times every day. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Take trazodone exactly as directed. Do not take more or less of it take it more often or take it for a longer time than prescribed by your doctor.Your doctor may start you on a low dose of trazodone and gradually increase your dose not more than once every 3 to 4 days. Your doctor may decrease your dose once your condition is controlled.Trazodone controls depression but does not cure it. It may take 2 weeks or longer before you feel the full benefit of trazodone. Continue to take trazodone even if you feel well. Do not stop taking trazodone without talking to your doctor. Your doctor will probably decrease your dose gradually. Buy TRAZONIL Desyrel and other Prescription Drugs 16 products online at Medstore. Buy Online at Medstore - Click Here!
About TRAZONIL Desyrel: Product Type: Prescription Drugs 16 TRAZONIL ( Desyrel GENERIC Trazadone Hcl ) TRAZONIL (Desyrel GENERIC Trazadone Hcl) Desyrel GENERIC Trazadone Hcl 100mg 200(2 x 100) Tablets 100mg 400(4 x 100) Tablets 100mg 100 Tablets 50mg 400(4 x 100) Tablets 50mg 200(2 x 100) Tablets 50mg 100 Tablets Desyrel GENERIC Trazadone Hcl TRAZONIL
View more Prescription Drugs 16 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
